Arabidopsis thaliana Mediator in development\, stress response and light signaling'
Place: Lecture hall\, Betula\, Bldg. 6M
DTSTART;TZID=Europe/Stockholm:20111125T150000
DTEND;TZID=Europe/Stockholm:20111125T160000
SUMMARY:Seminar - Stefan Björklund: The function of Arabidopsis thaliana Me
diator in development\, stress response and light signaling
URL:http://www.ucmr.umu.se/about-ucmr/events/162-ucmr-calendar/164-seminar/
140-seminar-stefan-bjoerklund-the-function-of-arabidopsis-thaliana-mediato
r-in-development-stress-response-and-light-signaling.html
X-ALT-DESC;FMTTYPE=TEXT/HTML:The 'National and International' Seminar Serie
s\, Fall 2011
Speaker: Stefan Björklund\, Medical Chemistry and
Biophysics\, Umeå University
Title: 'The function of Arabi
dopsis thaliana Mediator in development\, stress response and light s
ignaling'
Place: Lecture hall\, Betula\, Bldg. 6M
END:VEVENT
BEGIN:VEVENT
UID:46e0da1dd3a10d5c8a3f615d05580182http://www.ucmr.umu.se
DTSTAMP:20260429T212606Z
CATEGORIES:Seminar
DESCRIPTION:KBC Lecture
\nTage-Erlander Professor 2011
\n \n
Paul Helquist
\nDepartment of Chemistry & Bi
ochemistry\, University of Notre Dame\, Notre Dame\, Indiana
\n
\nTitle:
\nFrom Simple Diene Chemistry to Therapies for R
are and Neglected Diseases
\n
\nAbstract
\nIn
a joint set of ventures\, the Wiest and Helquist laboratories at Notre Dam
e\, specializing in computational chemistry and drug synthesis\, respectiv
ely\, are supported by various funding mechanisms to reach out to investig
ators in other fields and at many institutions to form multi-disciplinary
collaborative teams for the purpose of drug development. Most often\, the
external collaborators are at medical schools or other biomedical institut
ions and have major strengths in biological or clinical studies but do not
have the chemistry expertise required for drug development. These collabo
rators have often identified a potential therapeutic protein target from c
ellular studies\, or they have conducted compound screenings to identify i
nitial hits. The next logical steps in these investigations are the design
of protein binders or hit optimization\, requiring the computational and
synthetic chemistry input of our laboratories. The resulting compounds are
provided back to the external collaborators and other appropriate parties
for more extensive biological studies. Over the past few years\, these co
llaborative ties have been established with many investigators at Cornell
University Weill College of Medicine\, Tufts University Medical School\, C
olumbia University College of Physicians and Surgeons\, Washington Univers
ity School of Medicine\, University of Texas Southwestern Medical Center\,
Broad Institute\, Dana-Farber Cancer Institute\, Purdue University\, Stat
e University of New York at Albany\, and Biological Sciences at Notre Dame
.
\nThis presentation will place emphasis on the history of our deve
lopment of synthetic methods for dienes\, especially with colleagues in Sw
eden\, and the synthesis of target compounds as potential drugs for treati
ng cancer and a rare\, inherited disease.
\n
\n
Abstract with refer
ences for download here
\nMore information about the Tage Erlander professor 2011
DTSTART;TZID=Europe/Stockholm:20111214T130000
DTEND;TZID=Europe/Stockholm:20111214T140000
SUMMARY:KBC Lecture - Paul Helquist: From Simple Diene Chemistry to Therapi
es for Rare and Neglected Diseases
URL:http://www.ucmr.umu.se/about-ucmr/events/162-ucmr-calendar/164-seminar/
152-kbc-lecture-paul-helquist-from-simple-diene-chemistry-to-therapies-for
-rare-and-neglected-diseases.html
X-ALT-DESC;FMTTYPE=TEXT/HTML:KBC Lecture
\nTage-Erlander Professor
2011
\n
\nPaul Helquist
\nDepartment
of Chemistry & Biochemistry\, University of Notre Dame\, Notre Dame\, Indi
ana
\n
\nTitle:
\nFrom Simple Diene Chemistry t
o Therapies for Rare and Neglected Diseases
\n
\nAbs
tract
\nIn a joint set of ventures\, the Wiest and Helquist laborato
ries at Notre Dame\, specializing in computational chemistry and drug synt
hesis\, respectively\, are supported by various funding mechanisms to reac
h out to investigators in other fields and at many institutions to form mu
lti-disciplinary collaborative teams for the purpose of drug development.
Most often\, the external collaborators are at medical schools or other bi
omedical institutions and have major strengths in biological or clinical s
tudies but do not have the chemistry expertise required for drug developme
nt. These collaborators have often identified a potential therapeutic prot
ein target from cellular studies\, or they have conducted compound screeni
ngs to identify initial hits. The next logical steps in these investigatio
ns are the design of protein binders or hit optimization\, requiring the c
omputational and synthetic chemistry input of our laboratories. The result
ing compounds are provided back to the external collaborators and other ap
propriate parties for more extensive biological studies. Over the past few
years\, these collaborative ties have been established with many investig
ators at Cornell University Weill College of Medicine\, Tufts University M
edical School\, Columbia University College of Physicians and Surgeons\, W
ashington University School of Medicine\, University of Texas Southwestern
Medical Center\, Broad Institute\, Dana-Farber Cancer Institute\, Purdue
University\, State University of New York at Albany\, and Biological Scien
ces at Notre Dame.
\nThis presentation will place emphasis on the hi
story of our development of synthetic methods for dienes\, especially with
colleagues in Sweden\, and the synthesis of target compounds as potential
drugs for treating cancer and a rare\, inherited disease.
\n
\n
Ab
stract with references for download here
\nMore information about the Tage Erlander profess
or 2011
END:VEVENT
BEGIN:VEVENT
UID:aa7e0f6e0cec59f4edf93a20e2ef56dbhttp://www.ucmr.umu.se
DTSTAMP:20260429T212606Z
CATEGORIES:Seminar
DESCRIPTION:Department of Clinical Microbiology
Extra Seminar
Title:
Resolving the stage-specific contribution of the anti-apopt
otic proteins to humoral immunity
Ingela Vikström
Wa
lter and Eliza Hall Institute
Melbourne\, Australia
Place:
Betula\, University Hospital\, building 6 M
-----------
<
br />Dr Ingela Vikström completed her PhD at the Dept. Med Biosciences\, U
meå University in 2006. She then relocated to Melbourne Australia were she
is currently a post doctoral fellow at the Walter and Eliza Hall Institut
e. Some of her recent publications include:
Vikstrom I\, Tarlin
ton DM. B cell memory and the role of apoptosis in its formation. Mol Immu
nol. 2011 48:1301-6.
Vikstrom I\, Carotta S\, Lüthje K\, Peperzak V\
, Jost PJ\, Glaser S\, Busslinger M\, Bouillet P\, Strasser A\, Nutt SL\,
Tarlinton DM. Mcl-1 is essential for germinal center formation and B cell
memory. Science. 2010 330:1095-9
Carrington EM\, Vikstrom IB\, Light
A\, Sutherland RM\, Londrigan SL\, Mason KD\, Huang DC\, Lew AM\, Tarlinto
n DM. BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins rep
resent another class of selective immune modulatory drugs. Proc Natl Acad
Sci U S A. 2010 107:10967-71.
DTSTART;TZID=Europe/Stockholm:20111221T140000
DTEND;TZID=Europe/Stockholm:20111221T150000
SUMMARY:Seminar - Ingela Vikström: Resolving the stage-specific contributio
n of the anti-apoptotic proteins to humoral immunity
URL:http://www.ucmr.umu.se/about-ucmr/events/162-ucmr-calendar/164-seminar/
155-seminar-ingela-vikstroem-resolving-the-stage-specific-contribution-of-
the-anti-apoptotic-proteins-to-humoral-immunity.html
X-ALT-DESC;FMTTYPE=TEXT/HTML:Department of Clinical Microbiology
Extra Seminar
Title:
Resolving the stage-specific contribution
of the anti-apoptotic proteins to humoral immunity
Ingela Vikst
röm
Walter and Eliza Hall Institute
Melbourne\, Australia<
br />
Place: Betula\, University Hospital\, building 6 M
-
----------
Dr Ingela Vikström completed her PhD at the Dept. Me
d Biosciences\, Umeå University in 2006. She then relocated to Melbourne A
ustralia were she is currently a post doctoral fellow at the Walter and El
iza Hall Institute. Some of her recent publications include:
Vi
kstrom I\, Tarlinton DM. B cell memory and the role of apoptosis in its fo
rmation. Mol Immunol. 2011 48:1301-6.
Vikstrom I\, Carotta S\, Lüthj
e K\, Peperzak V\, Jost PJ\, Glaser S\, Busslinger M\, Bouillet P\, Strass
er A\, Nutt SL\, Tarlinton DM. Mcl-1 is essential for germinal center form
ation and B cell memory. Science. 2010 330:1095-9
Carrington EM\, Vik
strom IB\, Light A\, Sutherland RM\, Londrigan SL\, Mason KD\, Huang DC\,
Lew AM\, Tarlinton DM. BH3 mimetics antagonizing restricted prosurvival B
cl-2 proteins represent another class of selective immune modulatory drugs
. Proc Natl Acad Sci U S A. 2010 107:10967-71.
END:VEVENT
BEGIN:VEVENT
UID:9f3e4d7f1163f9514468536793ef5202http://www.ucmr.umu.se
DTSTAMP:20260429T212606Z
CATEGORIES:Seminar
DESCRIPTION:Department of Clinical Microbiology
Extra Seminar
Title:
High-Throughput Screening in an Academic Setting\,
a Bona Fide Path to Novel Therapeutics and Tool Molecules?
\n
Speaker:
Kurt Lackovic
Walter and Eli
za Hall Institute Melbourne\, Australia
Place: Betula\, Univ
ersity Hospital\, building 6 M
The Walter and E
liza Hall Institute of Medical Research was one of the first academic inst
itutions in the world to establish a high-throughput screening facility. H
ow this Facility operates\, along with the format of projects\, outcomes t
o date\, examples of projects\, and recent expansion to include high-conte
nt screening will be discussed.
\n
\nBiography Paragraph:
\nDr Kurt Lackovic completed his PhD in analytical chemistry in 2003. H
e then relocated to Sweden for his initial post doctoral placement\, at th
e Department of Medical Biosciences\, Umeå University\, Sweden. Dr Lackovi
c returned to Melbourne in October 2006\, immediately taking a position in
the WEHI High-Throughput Chemical Screening (HTCS) Facility. In his curre
nt role\, Dr Lackovic is responsible for managing collaborative research p
rojects seeking lead-like molecules across a broad range of target classes
and disease types\, developing novel techniques\, and reporting findings.
In addition\, he is responsible for the HTCS Facility's high-content imag
ing capabilities.
\n
Recent publications include:
Croker et al. Fas-mediated neutrophil apoptosis is accelerated
by Bid\, Bak\, and Bax and inhibited by Bcl-2 and Mcl-1. Proc Natl AcadSci
U S A. 2011 108:13135-40.
Lackovic K\, Parisot JP\, Sleebs N\, Bae
ll JB\, Debien L\, Watson KG\, Curtis JM\,Handman E\, Street IP\, Kedziers
ki L. Inhibitors of Leishmania GDP-mannose pyrophosphorylase identified by
high-throughput screening of small-molecule chemical library. Antimicrob
Agents Chemother. 2010 54:1712-9.
DTSTART;TZID=Europe/Stockholm:20111222T140000
DTEND;TZID=Europe/Stockholm:20111222T150000
SUMMARY:Seminar- Kurt Lackovic: High-Throughput Screening in an Academic Se
tting\, a Bona Fide Path to Novel Therapeutics and Tool Molecules?
URL:http://www.ucmr.umu.se/about-ucmr/events/162-ucmr-calendar/164-seminar/
157-seminar-kurt-lackovic-high-throughput-screening-in-an-academic-setting
-a-bona-fide-path-to-novel-therapeutics-and-tool-molecules.html
X-ALT-DESC;FMTTYPE=TEXT/HTML:Department of Clinical Microbiology
E
xtra Seminar
Title:
High-Throughput Screening in an Ac
ademic Setting\, a Bona Fide Path to Novel Therapeutics and Tool Molecules
?
\nSpeaker:
Kurt Lackovic
Walter and Eliza Hall Institute Melbourne\, Australia
Pla
ce: Betula\, University Hospital\, building 6 M
The Walter and Eliza Hall Institute of Medical Research was one of the fi
rst academic institutions in the world to establish a high-throughput scre
ening facility. How this Facility operates\, along with the format of proj
ects\, outcomes to date\, examples of projects\, and recent expansion to i
nclude high-content screening will be discussed.
\n
\nBiograp
hy Paragraph:
\nDr Kurt Lackovic completed his PhD in analytical che
mistry in 2003. He then relocated to Sweden for his initial post doctoral
placement\, at the Department of Medical Biosciences\, Umeå University\, S
weden. Dr Lackovic returned to Melbourne in October 2006\, immediately tak
ing a position in the WEHI High-Throughput Chemical Screening (HTCS) Facil
ity. In his current role\, Dr Lackovic is responsible for managing collabo
rative research projects seeking lead-like molecules across a broad range
of target classes and disease types\, developing novel techniques\, and re
porting findings. In addition\, he is responsible for the HTCS Facility's
high-content imaging capabilities.
\n
Recent publicatio
ns include:
Croker et al. Fas-mediated neutrophil apoptosi
s is accelerated by Bid\, Bak\, and Bax and inhibited by Bcl-2 and Mcl-1.
Proc Natl AcadSci U S A. 2011 108:13135-40.
Lackovic K\, Parisot JP
\, Sleebs N\, Baell JB\, Debien L\, Watson KG\, Curtis JM\,Handman E\, Str
eet IP\, Kedzierski L. Inhibitors of Leishmania GDP-mannose pyrophosphoryl
ase identified by high-throughput screening of small-molecule chemical lib
rary. Antimicrob Agents Chemother. 2010 54:1712-9.
END:VEVENT
BEGIN:VEVENT
UID:66967b99126f1a297f68a1e883a93a8bhttp://www.ucmr.umu.se
DTSTAMP:20260429T212606Z
CATEGORIES:Seminar
DESCRIPTION:Department of Chemistry announces:
\nSpeaker:
\n
Hindrik Mulder\, Professor\, MD
Unit of Molecular Metabolism Lund Un
iversity
Diabetes Centre Department of Clinical Sciences
Title:
Mitochondrial dysfunction in Type 2 Diabetes - a role for TF
B1M Host: Henrik Antti\, Department of Chemistry
\nPlace:
Biolo
gihuset BiA 201 (Biology building)
DTSTART;TZID=Europe/Stockholm:20120126T153000
DTEND;TZID=Europe/Stockholm:20120126T163000
SUMMARY:Seminar - Hindrik Mulder: Mitochondrial dysfunction in Type 2 Diab
etes - a role for TFB1M
URL:http://www.ucmr.umu.se/about-ucmr/events/162-ucmr-calendar/164-seminar/
165-seminar-hindrik-mulder-mitochondrial-dysfunction-in-type-2-diabetes-a-
role-for-tfb1m.html
X-ALT-DESC;FMTTYPE=TEXT/HTML:Department of Chemistry announces:
\n
Speaker:
\nHindrik Mulder\, Professor\, MD
Unit of Molecular M
etabolism Lund University
Diabetes Centre Department of Clinical Sci
ences
Title:
Mitochondrial dysfunction in Type 2 Diabete
s - a role for TFB1M Host: Henrik Antti\, Department of Chemistry
\n
Place:
Biologihuset BiA 201 (Biology building)
END:VEVENT
BEGIN:VEVENT
UID:071f5a28a33a79231a4621b8f7d3c546http://www.ucmr.umu.se
DTSTAMP:20260429T212606Z
CATEGORIES:Seminar
DESCRIPTION:Clinical Microbiology / Virology
Extra Seminar
Speak
er:
Urs Greber
Institute of Molecular Life Scie
nces\, University of Zurich\, Switzerland
Title:
Through
the eyes of an adenovirus -- insights into host trafficking & beyond
Place:
Lecture hall: Department of Infectious Diseases. Buildi
ng 24\, University Hospital
'Undervisningsnod K0'
Host: Ya
-fang Mei\, Department of Clinical Microbiology/Virology
E-mail: This email address is being p
rotected from spambots. You need JavaScript enabled to view it.\n document.getElementById('cloak3a5872ea2ab5b91
7c604965b22028faf').innerHTML = ''\;\n var prefix = 'm\;a' + 'il\;'
+ 't\;o'\;\n var path = 'hr' + 'ef' + '='\;\n var addy3a5872ea2ab5b917c
604965b22028faf = 'Me\;i\;.Ya\;-fa\;ng' + '@\;'\;\n addy3a
5872ea2ab5b917c604965b22028faf = addy3a5872ea2ab5b917c604965b22028faf + 'c
li\;mi\;' + '.\;' + 'u\;mu\;' + '.\;' + 'se\;'\;
\n var addy_text3a5872ea2ab5b917c604965b22028faf = 'Me\;i\;.Ya\;
-fa\;ng' + '@\;' + 'cli\;mi\;' + '.\;' + 'u\;mu\;
' + '.\;' + 'se\;'\;document.getElementById('cloak3a5872ea2ab5b917c
604965b22028faf').innerHTML += ''+addy_text3a5872ea2ab5b917c604965b22
028faf+'<\/a>'\;\n
DTSTART;TZID=Europe/Stockholm:20120202T100000
DTEND;TZID=Europe/Stockholm:20120202T110000
SUMMARY:Seminar - Urs Greber: Through the eyes of an adenovirus -- insight
s into host trafficking & beyond
URL:http://www.ucmr.umu.se/about-ucmr/events/162-ucmr-calendar/164-seminar/
190-seminar-urs-greber-through-the-eyes-of-an-adenovirus-insights-into-hos
t-trafficking-beyond.html
X-ALT-DESC;FMTTYPE=TEXT/HTML:Clinical Microbiology / Virology
Extra S
eminar
Speaker:
Urs Greber
Institute of Mo
lecular Life Sciences\, University of Zurich\, Switzerland
Titl
e:
Through the eyes of an adenovirus -- insights into host traffick
ing & beyond
Place:
Lecture hall: Department of Infectious
Diseases. Building 24\, University Hospital
'Undervisningsnod K0'
Host: Ya-fang Mei\, Department of Clinical Microbiology/Virology<
br />E-mail: This email a
ddress is being protected from spambots. You need JavaScript enabled to vi
ew it.
END:VEVENT
BEGIN:VEVENT
UID:678d0784d04be69f74089c610fa95233http://www.ucmr.umu.se
DTSTAMP:20260429T212606Z
CATEGORIES:Seminar
DESCRIPTION:Department of Clinical Microbiology
\nExtra - Seminar<
/p>\n
Speaker:
\nOlli Salin
Department of Bi
ological Sciences Åbo Akademi University\, Åbo\, Finland
\nTitle:
Approaches to discover antichlamydial compounds
\n<
p> \nPlace: KB3A9 Lilla hörsalen KBC
DTSTART;TZID=Europe/Stockholm:20120208T103000
DTEND;TZID=Europe/Stockholm:20120208T113000
SUMMARY:Seminar . Olli Salin: Approaches to discover antichlamydial compoun
ds
URL:http://www.ucmr.umu.se/about-ucmr/events/162-ucmr-calendar/164-seminar/
185-seminar-olli-salin-approaches-to-discover-antichlamydial-compounds.htm
l
X-ALT-DESC;FMTTYPE=TEXT/HTML:Department of Clinical Microbiology
\nExtra - Seminar
\nSpeaker:
\nOlli Salin
Department of Biological Sciences Åbo Akademi University\, Åbo\, Finland<
/p>\n
Title:
Approaches to discover antichlamydial compound
s
\n
\nPlace: KB3A9 Lilla hörsalen KBC
END:VEVENT
BEGIN:VEVENT
UID:37f8234087a68734dd90c201bdacf40fhttp://www.ucmr.umu.se
DTSTAMP:20260429T212606Z
CATEGORIES:Seminar
DESCRIPTION:Medical Biochemistry and Biophysics Seminar Series\, sp
ring 2012
Anders Nordström\, Departme
nt of Molecular Biology\, Umeå University
Title: Quantitative and Kinetic Metabolomics to study mechanisms of drug resis
tance
Place: KB3A9\, Lilla hörsalen\, KBC
Host: Richard Lundmark
DTSTART;TZID=Europe/Stockholm:20120214T151500
DTEND;TZID=Europe/Stockholm:20120214T151500
SUMMARY:Seminar - Anders Nordström: Quantitative and Kinetic Metabolomics t
o study mechanisms of drug resistance
URL:http://www.ucmr.umu.se/about-ucmr/events/162-ucmr-calendar/164-seminar/
186-seminar-anders-nordstroem-quantitative-and-kinetic-metabolomics-to-stu
dy-mechanisms-of-drug-resistance.html
X-ALT-DESC;FMTTYPE=TEXT/HTML:Medical Biochemistry and Biophysics Se
minar Series\, spring 2012
Anders Nordström\, Department of Molecular Biology\, Umeå University
Title: Quantitative and Kinetic Metabolomics to study mechani
sms of drug resistance
Place: KB3A9\, Lilla hö
rsalen\, KBC
Host: Richard Lundmark
END:VEVENT
BEGIN:VEVENT
UID:981a470f052075fae8f01480399b43adhttp://www.ucmr.umu.se
DTSTAMP:20260429T212606Z
CATEGORIES:Seminar
DESCRIPTION:Clinical Microbiology / Virology
Extra Seminar
Speak
er:
Urs Greber
Institute of Molecular Life Scie
nces\, University of Zurich\, Switzerland
Title:
Through
the eyes of an adenovirus -- insights into host trafficking & beyond
Place:
Lecture hall: Department of Infectious Diseases. Buildi
ng 24\, University Hospital
'Undervisningsnod K0'
Host: Ya
-fang Mei\, Department of Clinical Microbiology/Virology
E-mail: This email address is being p
rotected from spambots. You need JavaScript enabled to view it.\n document.getElementById('cloak617efbd325f34b5
50a898b07aa969448').innerHTML = ''\;\n var prefix = 'm\;a' + 'il\;'
+ 't\;o'\;\n var path = 'hr' + 'ef' + '='\;\n var addy617efbd325f34b550
a898b07aa969448 = 'Me\;i\;.Ya\;-fa\;ng' + '@\;'\;\n addy61
7efbd325f34b550a898b07aa969448 = addy617efbd325f34b550a898b07aa969448 + 'c
li\;mi\;' + '.\;' + 'u\;mu\;' + '.\;' + 'se\;'\;
\n var addy_text617efbd325f34b550a898b07aa969448 = 'Me\;i\;.Ya\;
-fa\;ng' + '@\;' + 'cli\;mi\;' + '.\;' + 'u\;mu\;
' + '.\;' + 'se\;'\;document.getElementById('cloak617efbd325f34b550
a898b07aa969448').innerHTML += ''+addy_text617efbd325f34b550a898b07aa
969448+'<\/a>'\;\n
DTSTART;TZID=Europe/Stockholm:20120302T100000
DTEND;TZID=Europe/Stockholm:20120302T110000
SUMMARY:Seminar - Urs Greber: Through the eyes of an adenovirus -- insight
s into host trafficking & beyond
URL:http://www.ucmr.umu.se/about-ucmr/events/162-ucmr-calendar/164-seminar/
191-seminar-urs-greber-through-the-eyes-of-an-adenovirus-insights-into-hos
t-trafficking-beyond.html
X-ALT-DESC;FMTTYPE=TEXT/HTML:Clinical Microbiology / Virology
Extra S
eminar
Speaker:
Urs Greber
Institute of Mo
lecular Life Sciences\, University of Zurich\, Switzerland
Titl
e:
Through the eyes of an adenovirus -- insights into host traffick
ing & beyond
Place:
Lecture hall: Department of Infectious
Diseases. Building 24\, University Hospital
'Undervisningsnod K0'
Host: Ya-fang Mei\, Department of Clinical Microbiology/Virology<
br />E-mail: This email a
ddress is being protected from spambots. You need JavaScript enabled to vi
ew it.
END:VEVENT
BEGIN:VEVENT
UID:5018be7860acbd0610f3b451a383a1f9http://www.ucmr.umu.se
DTSTAMP:20260429T212606Z
CATEGORIES:Seminar
DESCRIPTION:Joint seminar UCMM - UCMR- MIMS - KBC
\nSpeaker:
\n
Myles Axton
Editor\, Nature Genetics
\n
Title:
\nPublishing your work in Nature journals<
/p>\n
\nHost:
\nHelena Edlund
\n
\nPlace: Sto
ra Hörsalen KB3B1\, KBC
DTSTART;TZID=Europe/Stockholm:20120502T140000
DTEND;TZID=Europe/Stockholm:20120502T150000
SUMMARY:Seminar - Myles Axton: Publishing your work in Nature journals
URL:http://www.ucmr.umu.se/about-ucmr/events/162-ucmr-calendar/164-seminar/
195-seminar-myles-axton-publishing-your-work-in-nature-journals.html
X-ALT-DESC;FMTTYPE=TEXT/HTML:Joint seminar UCMM - UCMR- MIMS - KBC
\n
Speaker:
\nMyles Axton
Editor\, Nature Gene
tics
\n
Title:
\nPublishing your work in Nature j
ournals
\n
\nHost:
\nHelena Edlund
\n \n
Place: Stora Hörsalen KB3B1\, KBC
END:VEVENT
BEGIN:VEVENT
UID:b19863b60a719aad7fe0a497d688b4f9http://www.ucmr.umu.se
DTSTAMP:20260429T212606Z
CATEGORIES:Seminar
DESCRIPTION:
EMBL Partnership for Molecular Medicine (FIMM - M
IMS - NCMM) joint Special Seminar at the Biomedicum in Helsinki.<
br />Video transfer of the talk to Umeå and Oslo simultanously.
John Overington\, EMBL Outstation - Hinxton\, European B
ioinformatics Institute\, Cambridge\, UK
'A data mining
synthesis approach to the discovery of impersonalised\, robust and safe t
herapies'
Abstract:
Adverse Drug Reactions\, ADRs\, are a major burden
on healthcare systems\, and arguably\, if patients can be stratified\, mor
e novel therapies\, tolerable in particular genotyped groups could be deve
loped and launched. We have taken a data synthesis approach to explore ADR
s and some of the underlying molecular recognition and pharmacokinetic con
cepts. We then derived a novel drug combination strategy which theoretical
ly can greatly improve the safety of current therapies and also lead to mo
re predictable and consistent patient population response.
Summary for downl
oad
Place: Major Groove\, Department of Mo
lecular Biology\, bldg 6L\, University Hospital Area
Or
ganizer in Sweden: Åke Forsberg
Host at FIMM in Finl
and: Heidi Virtanen
DTSTART;TZID=Europe/Stockholm:20120531T103000
DTEND;TZID=Europe/Stockholm:20120531T113000
SUMMARY:Video-Transfer-Seminar - John Overington: A data mining synthesis a
pproach to the discovery of impersonalised\, robust and safe therapies
URL:http://www.ucmr.umu.se/about-ucmr/events/162-ucmr-calendar/164-seminar/
201-video-transfer-seminar-john-overington-a-data-mining-synthesis-approac
h-to-the-discovery-of-impersonalised-robust-and-safe-therapies.html
X-ALT-DESC;FMTTYPE=TEXT/HTML:
EMBL Partnership for Molecular M
edicine (FIMM - MIMS - NCMM) joint Special Seminar at the Biomedicum in He
lsinki.
Video transfer of the talk to Umeå and Oslo simultan
ously.
John Overington\, EMBL Outstation - Hin
xton\, European Bioinformatics Institute\, Cambridge\, UK
'A data mining synthesis approach to the discovery of impersonalised\,
robust and safe therapies'
Abstract:<
br />Adverse Drug Reactions\, ADRs\, ar
e a major burden on healthcare systems\, and arguably\, if patients can be
stratified\, more novel therapies\, tolerable in particular genotyped gro
ups could be developed and launched. We have taken a data synthesis approa
ch to explore ADRs and some of the underlying molecular recognition and ph
armacokinetic concepts. We then derived a novel drug combination strategy
which theoretically can greatly improve the safety of current therapies an
d also lead to more predictable and consistent patient population response
.
Summary for download
Place: Major Groove\,
Department of Molecular Biology\, bldg 6L\, University Hospital Area
Organizer in Sweden: Åke Forsberg
Hos
t at FIMM in Finland: Heidi Virtanen
END:VEVENT
END:VCALENDAR